Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation

American Journal of Hematology

Volumn 51, Issue 4, 1996, Pages 255-260

  Wada, Hideo ^a   Wakita, Yoshihiro ^a   Nakase, Tsutomu ^a   Shimura, Minori ^a   Hiyoyama, Katuyo ^a   Nagaya, Shozaburo ^a   Deguchi, Hiroshi ^a   Mori, Yoshitaka ^a   Kaneko, Toshihiro ^b,c   Deguchi, Katsumi ^d   Fujii, Junichi ^d   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY   (Japan)

^b Mie Red Cross Blood Center   (Japan)

^c MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Division of Respiratory Medicine   (Japan)

Author keywords

DIC; PIC; pre DIC; SFM; TAT

Indexed keywords

ANTIPLASMIN; FIBRIN DEGRADATION PRODUCT; FIBRIN MONOMER; PLASMIN; THROMBIN ANTITHROMBIN III COMPLEX; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD COAGULATION TESTS; DISSEMINATED INTRAVASCULAR COAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LEUKEMIA; MOLECULAR SEQUENCE DATA; NEOPLASMS; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEPSIS;

EID: 9244249233     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199604)51:4<255::AID-AJH1>3.0.CO;2-V     Document Type: Article

References (21)

1. Colman RT, Robboy SJ, Minna ID: Disseminated intravascular coagulation (DIC); An approach. Am J Med 52:679-689, 1974.
2. Gralnick HR, Bargrey J, Abrell E: Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia. Am J Med 52:167-174, 1972.
3. Pelzer H, Schwarz A, Heinburger N: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 59:101-106, 1987.
4. Mimuro J, Koike Y, Sumi Y, Aoki N: Monoclonal antibodies to discrete regions in α2-plasmin inhibitor. Blood 69:446-453, 1987.
5. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ, Wyatt D, Bundesen PG: Am immunoassay for human D-dimer using monoclonal antibodies. Thromb Res, 31:767-778, 1983.
6. Godal HC, Abildgarred U: Gelation of soluble fibrin in plasma by ethanol. Scand J Haematol 3:343-350, 1966.
7. Weiding JU, Eisinger G, Kostering H: Determination of soluble fibrin by turbidimetry of its protamine sulphate-induced paracoagulation. J Clin Chem Clin Biochem, 27:57-64, 1989.
8. Largo R, Heller V, Straub PW: Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers. Blood 47:991-1002, 1976.
9. Wiman B, Ranby M: Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay. Thromb Haemost 55:189-193, 1986.
10. Lill H, Spannagl M, Trauner A, Schramm W, Schuller D, Ofenloch-Haehnle B, Draeger B, Naser W, Dessauer A: A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo. Blood Coagul Fibrinol 4:97-102, 1993.
11. Kobayashi N, Maegawa T, Takada M, Tanaka H, Gonmori H: Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DlC in Japan. Bibl Haematol 49:265-275, 1987.
12. Wada H, Minamikawa K, Wakita Y, Nakase T, Kaneko T, Ohiwa M, Tamaki S, Deguchi A, Mori Y, Deguchi K, Shirakawa S, Suzuki K: Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 43:190-194, 1994.
13. Ohno H, Kosaki G, Kambayashi J, Imaoka S, Hirata F: FOY; [ethyl p-(6-guanidinohexanoxyloxy) benzoate] methaneslfonate as a serine protease inhibitor. I. Inhibition of thrombin and factor Xa in vitro. Thromb Res 19:579-588, 1980.
14. Ohno H, Kambayashi J, Chang SW, Kosaki G: FOY; [ethyl p-(6-guanidinohexanoxyloxy) benzoate] methaneslfonate as a serine protease inhibitor. II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin. Thromb Res 24:445-452, 1981.
15. Wada H, Tomeoku M, Deguchi A, Suzuki H, Mori Y, Ito M, Deguchi K, Shirakawa S: Anticoagulant activity in cell homogenate of adult T cell leukemia. Thomb Haemost 59:197-201, 1988.
16. Goldstein BJ, Mushlin AI: Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism. J Gen Intern Med 2:20-24, 1987.
17. Nieuwenhuizen W: Soluble fibrin as molecular marker for a pre-thrombotic state. A mini-review. Blood Coag Fibrinol 4:93-96, 1993.
18. Spannagl M, Trauner A, Birg A, Frank G, Hoffmann H, Siebeck M, Lill H: Sensitive detection of the activation state of blood coagulation in porcine DIC models by a new fibrin immunoassay. Blood Coagul Fibrinol 4:103-106, 1993.
19. Stibbe J: Monitoring the anticoagulant treatment of DIC and recurrent thrombosis in patients with malignancies using the measurement of "soluble fibrin" (FM-test, Chromogenix), F1 + 2 and TAT complexes. In Muller-Berghaus et al. (eds): "DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation." Amsterdam: Elsevier Science Publishers B.V., 1993, p 113.
20. Okajima K, Uchiba M, Murakami K, Okabe H, Takatsuki K: Determination of plasma fibrin monomers by a newly developed ELISA method in patients with disseminated intravascular coagulation. In Muller-Berghaus (ed): "DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation." Amsterdam: Elsevier Science Publishers B.V., 1993, p 113.
21. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Mori Y, Shiku H, the Mie DIC Study Group: Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Thromb Haemost 74:848, 1996.